Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer

被引:0
|
作者
Noel Pabalan
Ofelia Francisco-Pabalan
Lillian Sung
Hamdi Jarjanazi
Hilmi Ozcelik
机构
[1] Saint Louis University,College of Natural Sciences
[2] University Health Network,Analytical Genetics Technology Centre, Princess Margaret Hospital
[3] Hospital for Sick Children,Division of Hematology/Oncology
[4] Ontario Ministry of the Environment,Environmental Monitoring and Reporting Branch
[5] Mount Sinai Hospital,Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute
来源
Breast Cancer Research and Treatment | 2010年 / 124卷
关键词
Breast cancer; ERCC2; XPD; Asp312Asn; Lys751Gln; Adducts;
D O I
暂无
中图分类号
学科分类号
摘要
The excision repair cross-complementing group 2 gene (ERCC2) plays a key role in DNA repair. Several polymorphisms in the ERCC2 gene have been described, including the commonly occurring Lys751Gln and Asp312Asn polymorphisms. Studies investigating the association of these polymorphisms with breast cancer risk produced controversial results. To evaluate these associations presented in diverse populations, we have conducted a meta-analysis based on 40 studies from 33 publications in PubMed which included analyses of Lys751Gln (14,545 cases, 15,352 controls) and Asp312Asn polymorphisms (16,254 cases, 14,006 controls). Overall findings of both polymorphisms have implicated null effects (OR = 1.01–1.03) when the analyses were limited to the statistically powerful (≥80%) studies. Although modestly increased statistically significant breast cancer risk was detected in the underpowered studies (≤80%), removal of outliers resulted in null associations. Ethnic stratification showed non-significant and relatively null associations for both polymorphisms with breast cancer risk for the overall Caucasians as well as North American and the European sub-populations. Although statistically increased and decreased risks were observed for the homogenous populations of African-Americans (Lys751Gln, OR 1.25, 95% CI 1.03–1.53, P = 0.03) and Asians (Asp312Asn, ORs: 0.53–0.55, P values: 0.02–0.03), respectively, this may be the result of small sample size. Analyses of the homogeneous adduct studies, with relatively large sample size, exhibited increased risk for Lys751Gln (OR 1.20, 95% CI (1.02–1.41), P = 0.03) and Asp312Asn (OR 1.17 95% CI 1.02–1.34, P = 0.03) under the dominant genetic model. In conclusion, our results suggest null associations of both polymorphisms in the overall and the Caucasian subgroups, although some effects can be suggested for relatively smaller minority studies. Increased risk effect was more visible when the adduct studies are considered, suggesting the role of these polymorphisms in the presence of exposure to DNA damaging agents.
引用
收藏
页码:531 / 541
页数:10
相关论文
共 50 条
  • [1] Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer
    Pabalan, Noel
    Francisco-Pabalan, Ofelia
    Sung, Lillian
    Jarjanazi, Hamdi
    Ozcelik, Hilmi
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (02) : 531 - 541
  • [2] ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis
    Bo Chen
    Yong Zhou
    Ping Yang
    Xiao-Ting Wu
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 939 - 946
  • [3] ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis
    Chen, Bo
    Zhou, Yong
    Yang, Ping
    Wu, Xiao-Ting
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (06) : 939 - 946
  • [4] XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis
    Yan, Yulan
    Liang, Hongjie
    Light, Morning
    Li, Taijie
    Deng, Yan
    Li, Meng
    Li, Shan
    Qin, Xue
    TUMOR BIOLOGY, 2014, 35 (03) : 1907 - 1915
  • [5] XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis
    Li, Chunxiang
    Jiang, Zheng
    Liu, Xinghan
    MOLECULAR BIOLOGY REPORTS, 2010, 37 (01) : 301 - 309
  • [6] XPD Lys751Gln and Asp312Asn polymorphisms and bladder cancer risk: a meta-analysis
    Chunxiang Li
    Zheng Jiang
    Xinghan Liu
    Molecular Biology Reports, 2010, 37 : 301 - 309
  • [7] XPD Lys751Gln and Asp312Asn Polymorphisms and Gastric Cancer Susceptibility: A Meta-analysis of Case-control Studies
    Yin, Qing-Hua
    Liu, Chuan
    Hu, Jian-Bing
    Meng, Rong-Rong
    Li, Lian
    Wang, Ya-Jie
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (01) : 231 - 236
  • [8] ERCC2/XPD Lys751Gln and Asp312Asn Gene Polymorphism and Lung Cancer Risk A Meta-Analysis Involving 22 Case-Control Studies
    Zhan, Ping
    Wang, Qin
    Wei, Shu-Zhen
    Wang, Jing
    Qian, Qian
    Yu, Li-Ke
    Song, Yong
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1337 - 1345
  • [9] XPD Lys751Gln and Asp312Asn Polymorphisms and Susceptibility to Skin Cancer: A Meta-Analysis of 17 Case-control Studies
    Zhu, Hai-Li
    Bao, Ji-Ming
    Lin, Pei-Xin
    Li, Wen-Xia
    Zou, Zhen-Ning
    Huang, Ye-En
    Chen, Qing
    Shen, Hong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6619 - 6625
  • [10] Association Between XPD Lys751Gln and Asp312Asn Polymorphisms and Hepatocellular Carcinoma Risk A Systematic Review And Meta-Analysis
    Peng, Qiliu
    Li, Shan
    Lao, Xianjun
    Chen, Zhiping
    Li, Ruolin
    Qin, Xue
    MEDICINE, 2014, 93 (29) : e330